These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27416303)

  • 1. Copper(II) Ions Increase Plasminogen Activator Inhibitor Type 1 Dynamics in Key Structural Regions That Govern Stability.
    Bucci JC; Trelle MB; McClintock CS; Qureshi T; Jørgensen TJ; Peterson CB
    Biochemistry; 2016 Aug; 55(31):4386-98. PubMed ID: 27416303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen/deuterium exchange mass spectrometry reveals specific changes in the local flexibility of plasminogen activator inhibitor 1 upon binding to the somatomedin B domain of vitronectin.
    Trelle MB; Hirschberg D; Jansson A; Ploug M; Roepstorff P; Andreasen PA; Jørgensen TJ
    Biochemistry; 2012 Oct; 51(41):8256-66. PubMed ID: 22957734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolving distinct molecular origins for copper effects on PAI-1.
    Bucci JC; McClintock CS; Chu Y; Ware GL; McConnell KD; Emerson JP; Peterson CB
    J Biol Inorg Chem; 2017 Oct; 22(7):1123-1135. PubMed ID: 28913669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.
    Schroeck F; Arroyo de Prada N; Sperl S; Schmitt M; Viktor M
    Biol Chem; 2002; 383(7-8):1143-9. PubMed ID: 12437099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reduced, denatured somatomedin B domain of vitronectin refolds into a stable, biologically active molecule.
    Kamikubo Y; Kroon G; Curriden SA; Dyson HJ; Loskutoff DJ
    Biochemistry; 2006 Mar; 45(10):3297-306. PubMed ID: 16519524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a site on PAI-1 that binds to vitronectin outside of the somatomedin B domain.
    Schar CR; Jensen JK; Christensen A; Blouse GE; Andreasen PA; Peterson CB
    J Biol Chem; 2008 Oct; 283(42):28487-96. PubMed ID: 18658131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration.
    Zhou A; Huntington JA; Pannu NS; Carrell RW; Read RJ
    Nat Struct Biol; 2003 Jul; 10(7):541-4. PubMed ID: 12808446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin.
    Deng G; Royle G; Wang S; Crain K; Loskutoff DJ
    J Biol Chem; 1996 May; 271(22):12716-23. PubMed ID: 8662688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.
    Thompson LC; Goswami S; Ginsberg DS; Day DE; Verhamme IM; Peterson CB
    Protein Sci; 2011 Feb; 20(2):353-65. PubMed ID: 21280127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for defining binding sites involved in protein-protein interactions: analysis of the binding of plasminogen activator inhibitor 1 to the somatomedin domain of vitronectin.
    Royle G; Deng G; Seiffert D; Loskutoff DJ
    Anal Biochem; 2001 Sep; 296(2):245-53. PubMed ID: 11554720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor.
    Seiffert D; Ciambrone G; Wagner NV; Binder BR; Loskutoff DJ
    J Biol Chem; 1994 Jan; 269(4):2659-66. PubMed ID: 7507927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting molecular details and functional effects of the high-affinity copper binding site in plasminogen activator Inhibitor-1.
    Chu Y; Bucci JC; Peterson CB
    Protein Sci; 2021 Mar; 30(3):597-612. PubMed ID: 33345392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
    Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
    J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of plasminogen activator inhibitor-1 with vitronectin involve an extensive binding surface and induce mutual conformational rearrangements.
    Blouse GE; Dupont DM; Schar CR; Jensen JK; Minor KH; Anagli JY; Gårdsvoll H; Ploug M; Peterson CB; Andreasen PA
    Biochemistry; 2009 Mar; 48(8):1723-35. PubMed ID: 19193026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.
    Podor TJ; Singh D; Chindemi P; Foulon DM; McKelvie R; Weitz JI; Austin R; Boudreau G; Davies R
    J Biol Chem; 2002 Mar; 277(9):7529-39. PubMed ID: 11744725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of recombinant somatomedin B domain from vitronectin produced in Pichia pastoris.
    Kjaergaard M; Gårdsvoll H; Hirschberg D; Nielbo S; Mayasundari A; Peterson CB; Jansson A; Jørgensen TJ; Poulsen FM; Ploug M
    Protein Sci; 2007 Sep; 16(9):1934-45. PubMed ID: 17766387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional structure of the somatomedin B domain of vitronectin.
    Zhou A
    Protein Sci; 2007 Jul; 16(7):1502-8. PubMed ID: 17567740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.
    Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB
    Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of beta-strand 5A of plasminogen activator inhibitor-1 in regulation of its latency transition and inhibitory activity by vitronectin.
    Jensen S; Kirkegaard T; Pedersen KE; Busse M; Preissner KT; Rodenburg KW; Andreasen PA
    Biochim Biophys Acta; 2002 Jun; 1597(2):301-10. PubMed ID: 12044908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfide bonding arrangements in active forms of the somatomedin B domain of human vitronectin.
    Kamikubo Y; De Guzman R; Kroon G; Curriden S; Neels JG; Churchill MJ; Dawson P; Ołdziej S; Jagielska A; Scheraga HA; Loskutoff DJ; Dyson HJ
    Biochemistry; 2004 Jun; 43(21):6519-34. PubMed ID: 15157085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.